Citations (76)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
WilliamV. Bobo, ShannonC. Miller & BryantD. Martin. (2005) The Abuse Liability of Dextromethorphan Among Adolescents: A Review. Journal of Child & Adolescent Substance Abuse 14:4, pages 55-75.
Read now
Read now
D. A. SMITH, S. M. ABEL, R. HYLAND & B. C. JONES. (1998) Human cytochrome P450s: selectivity and measurement in vivo. Xenobiotica 28:12, pages 1095-1128.
Read now
Read now
F. Bochner, A. A. Somogyi & Z. R. Chen. (1994) Dextromethorphan metabolism in rat: Interstrain differences and the fate of individually administered oxidative metabolites. Xenobiotica 24:6, pages 543-552.
Read now
Read now
R.G. Morris, B.C. Sallustio, N.C. Saccoia, S. Mangas, L.K. Fergusson & C. Kassapidis. (1992) Application of an Improved HPLC Perhexiline Assay to Human Plasma Specimens. Journal of Liquid Chromatography 15:18, pages 3219-3232.
Read now
Read now
Articles from other publishers (72)
Lindsay Henderson, Katrina Claw, Erica Woodahl, Renee Robinson, Bert Boyer, Wylie Burke & Kenneth Thummel. (2018) P450 Pharmacogenetics in Indigenous North American Populations. Journal of Personalized Medicine 8:1, pages 9.
Crossref
Crossref
Tyler Mark Pierson, Hongjie Yuan, Eric D. Marsh, Karin Fuentes‐Fajardo, David R. Adams, Thomas Markello, Gretchen Golas, Dimitre R. Simeonov, Conisha Holloman, Anel Tankovic, Manish M. Karamchandani, John M. Schreiber, James C. Mullikin, Cynthia J. Tifft, Camilo Toro, Cornelius F. Boerkoel, Stephen F. Traynelis & William A. Gahl. (2014)
GRIN2A
mutation and early‐onset epileptic encephalopathy: personalized therapy with memantine
. Annals of Clinical and Translational Neurology 1:3, pages 190-198.
Crossref
Crossref
Andrew K. L. Goey, Irma Meijerman, Jos H. Beijnen & Jan H. M. Schellens. (2013) The effect of grape seed extract on the pharmacokinetics of dextromethorphan in healthy volunteers. European Journal of Clinical Pharmacology 69:11, pages 1883-1890.
Crossref
Crossref
Maris A. Cinelli, P. V. Narasimha Reddy, Peng-Cheng Lv, Jian-Hua Liang, Lian Chen, Keli Agama, Yves Pommier, Richard B. van Breemen & Mark Cushman. (2012) Identification, Synthesis, and Biological Evaluation of Metabolites of the Experimental Cancer Treatment Drugs Indotecan (LMP400) and Indimitecan (LMP776) and Investigation of Isomerically Hydroxylated Indenoisoquinoline Analogues as Topoisomerase I Poisons. Journal of Medicinal Chemistry 55:24, pages 10844-10862.
Crossref
Crossref
Jo-Anne Clarke, Murray Cutler, Inna Gong, Ute I. Schwarz, David Freeman & Monidipa Dasgupta. (2011) Cytochrome P450 2D6 Phenotyping in an Elderly Population With Dementia and Response to Galantamine in Dementia: A Pilot Study. The American Journal of Geriatric Pharmacotherapy 9:4, pages 224-233.
Crossref
Crossref
Taisuke Uchida, Takashi Watanabe, Ewoud J Van Hoogdalem & Saburo Higuchi. (1996) In-vitro Metabolism of YM17E, an Inhibitor of Acyl Coenzyme A: Cholesterol Acyltransferase, by Liver Microsomes in Man. Journal of Pharmacy and Pharmacology 48:10, pages 1049-1056.
Crossref
Crossref
Steven Gabardi, Danielle Carter, Spencer Martin & Keri Roberts. (2011) Recommendations for the proper use of nonprescription cough suppressants and expectorants in solid-organ transplant recipients. Progress in Transplantation 21:1, pages 6-14.
Crossref
Crossref
Steven GabardiDanielle CarterSpencer MartinKeri Roberts. (2011) Recommendations for the Proper Use of Nonprescription Cough Suppressants and Expectorants in Solid-Organ Transplant Recipients. Progress in Transplantation 21:1, pages 6-13.
Crossref
Crossref
Zheng Xu, Frederick E. Williams & Ming‐Cheh Liu. (2010) Developmental toxicity of dextromethorphan in zebrafish embryos/larvae. Journal of Applied Toxicology 31:2, pages 157-163.
Crossref
Crossref
Marios Spanakis, Ioannis S. Vizirianakis, Maria Mironidou-Tzouveleki & Ioannis Niopas. (2009)
A validated SIM GC/MS method for the simultaneous determination of dextromethorphan and its metabolites dextrorphan, 3-methoxymorphinan and 3-hydroxymorphinan in biological matrices and its application to
in vitro
CYP2D6 and CYP3A4 inhibition study
. Biomedical Chromatography 23:11, pages 1131-1137.
Crossref
Crossref
Linh M. Van, Sunil Sarda, Judith A. Hargreaves & Amin Rostami‐Hodjegan. (2009) Metabolism of Dextrorphan by CYP2D6 in Different Recombinantly Expressed Systems and its Implications for the In Vitro Assessment of Dextromethorphan Metabolism. Journal of Pharmaceutical Sciences 98:2, pages 763-771.
Crossref
Crossref
Laura K. Bechtel & Christopher P. Holstege. (2007) Criminal Poisoning: Drug-Facilitated Sexual Assault. Emergency Medicine Clinics of North America 25:2, pages 499-525.
Crossref
Crossref
D. Frank, U. Jaehde & U. Fuhr. (2007) Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping. European Journal of Clinical Pharmacology 63:4, pages 321-333.
Crossref
Crossref
Anita Siu & Richard Drachtman. (2007) Dextromethorphan: A Review of N-methyl-d-aspartate Receptor Antagonist in the Management of Pain. CNS Drug Reviews 13:1, pages 96-106.
Crossref
Crossref
Christian Funck-Brentano, Pierre-Yves Boëlle, Céline Verstuyft, Célia Bornert, Laurent Becquemont & Jean-Marie Poirier. (2005) Measurement of CYP2D6 and CYP3A4 activity in vivo with dextromethorphan: sources of variability and predictors of adverse effects in 419 healthy subjects. European Journal of Clinical Pharmacology 61:11, pages 821-829.
Crossref
Crossref
Silvana Borges, Lang Li, Mitchell A. Hamman, David R. Jones, Stephen D. Hall & J. Christopher Gorski. (2005) DEXTROMETHORPHAN TO DEXTRORPHAN URINARY METABOLIC RATIO DOES NOT REFLECT DEXTROMETHORPHAN ORAL CLEARANCE. Drug Metabolism and Disposition 33:7, pages 1052-1055.
Crossref
Crossref
Jin Young Kim, Sung Ill Suh, Ki-Jung Paeng & Moon Kyo In. (2004) Determination of Dextromethorphan and its Metabolite Dextrorphan in Human Hair by Gas Chromatography?Mass Spectrometry. Chromatographia 60:11-12, pages 703-707.
Crossref
Crossref
B. KuKanich & M. G. Papich. (2004) Plasma profile and pharmacokinetics of dextromethorphan after intravenous and oral administration in healthy dogs. Journal of Veterinary Pharmacology and Therapeutics 27:5, pages 337-341.
Crossref
Crossref
WenLin Sun & William D Wessinger. (2004) Characterization of the non-competitive antagonist binding site of the NMDA receptor in dark Agouti rats. Life Sciences 75:12, pages 1405-1415.
Crossref
Crossref
Mary Jayne Kennedy, Susan M. Abdel-Rahman, Angela D. M. Kashuba & J. Steven Leeder. (2004) Comparison of Various Urine Collection Intervals for Caffeine and Dextromethorphan Phenotyping in Children. The Journal of Clinical Pharmacology 44:7, pages 708-714.
Crossref
Crossref
Ai-Ming Yu, Jeffrey Idle, Tomas Herraiz, Adrian Kupfer & Frank Gonzalez. (2003) Pharmacogenetics 13:6, pages 307-319.
Crossref
Crossref
Shailesh S Vengurlekar, Jennifer Heitkamp, Fred McCush, Poonam R Velagaleti, Jerry H Brisson & Steven L Bramer. (2002) A sensitive LC-MS/MS assay for the determination of dextromethorphan and metabolites in human urine—application for drug interaction studies assessing potential CYP3A and CYP2D6 inhibition. Journal of Pharmaceutical and Biomedical Analysis 30:1, pages 113-124.
Crossref
Crossref
El-khalil Bendriss, Nektaria Markoglou & Irving W Wainer. (2001) High-performance liquid chromatography assay for simultaneous determination of dextromethorphan and its main metabolites in urine and in microsomal preparations. Journal of Chromatography B: Biomedical Sciences and Applications 754:1, pages 209-215.
Crossref
Crossref
G. P. Pageaux, J. Micallef, M. Barugola Nataf, J. C. Levron, B. Lacarelle, J. P. Le Moing, P. Bouhours & O. Blin. (2008) Pharmacokinetics of sabeluzole and dextromethorphan oxidation capacity in patients with severe hepatic dysfunction and healthy volunteers. British Journal of Clinical Pharmacology 51:2, pages 164-168.
Crossref
Crossref
Emmanuel Haffen, Gilles Paintaud, Michel Berard, Carole Masuyer, Yvette Bechtel & Pierre R. Bechtel. (2000) On the Assessment of Drug Metabolism by Assays of Codeine and Its Main Metabolites. Therapeutic Drug Monitoring 22:3, pages 258-265.
Crossref
Crossref
Benoit Bailey, Richard Daneman, Nick Daneman, Joel M Mayer & Gideon Koren. (2000) Discrepancy between CYP2D6 phenotype and genotype derived from post-mortem dextromethorphan blood level. Forensic Science International 110:1, pages 61-70.
Crossref
Crossref
Daniel S. Streetman, Joseph S. BertinoJrJr & Anne N. Nafziger. (2000) Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes. Pharmacogenetics 10:3, pages 187-216.
Crossref
Crossref
Marcel J. de Groot, Mark J. Ackland, Valerie A. Horne, Alexander A. Alex & Barry C. Jones. (1999) Novel Approach To Predicting P450-Mediated Drug Metabolism: Development of a Combined Protein and Pharmacophore Model for CYP2D6. Journal of Medicinal Chemistry 42:9, pages 1515-1524.
Crossref
Crossref
Yueh-Ching Chou, Jyh-Fei Liao, Wan-Ya Chang, Ming-Fang Lin & Chieh-Fu Chen. (1999) Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan. Brain Research 821:2, pages 516-519.
Crossref
Crossref
Laurie A. Zawertailo, Howard L. Kaplan, Usoa E. Busto, Rachel F. Tyndale & Edward M. Sellers. (1998) Psychotropic Effects of Dextromethorphan Are Altered by the CYP2D6 Polymorphism. Journal of Clinical Psychopharmacology 18:4, pages 332-337.
Crossref
Crossref
J.L. Plummer, K.D. Tran & G.K. Gourlay. (1997) Interaction between dextromethorphan and norpethidine in rats. European Journal of Pain 1:3, pages 191-196.
Crossref
Crossref
Hsien-Yuan Lane, Hwei-Chuang Deng, Shih-Ming Huang, Wei-Herng Hu, Wen-Ho Chang & Oliver Yoa-Pu Hu. (1996) Low frequency of dextromethorphan O-demethylation deficiency in a Chinese population*. Clinical Pharmacology & Therapeutics 60:6, pages 696-698.
Crossref
Crossref
Y. M. Irshaid, H. F. Al-Hadidi, A. Latif, F. Awwadi, M. Al-Zoubi & N. M. Rawashdeh. (1996) Dextromethorphan metabolism in Jordanians: Dissociation of dextromethorphan O-demethylation from debrisoquine 4-hydroxylation. European Journal of Drug Metabolism and Pharmacokinetics 21:4, pages 301-307.
Crossref
Crossref
Deborah A. Capon, Felix Bochner, Nicole Kerry, Gerd Mikus, Catherine Danz & Andrew A. Somogyi. (1996) The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans*. Clinical Pharmacology & Therapeutics 60:3, pages 295-307.
Crossref
Crossref
LARRY ERESHEFSKY. (1996) Drug-Drug Interactions Involving Antidepressants: Focus on Venlafaxine. Journal of Clinical Psychopharmacology 16:SUPPLEMENT 2, pages 37S-50S.
Crossref
Crossref
Jean-Philippe Kévorkian, Catherine Michel, Ute Hofmann, Evelyne Jacqz-Aigrain, Heyo K. Kroemer, Marie-Noëlle Peraldi, Michel Eichelbaum, Patrice Jaillon & Christian Funck-Brentano. (1996) Assessment of individual CYP2D6 activity in extensive metabolizers with renal failure: Comparison of sparteine and dextromethorphan*. Clinical Pharmacology & Therapeutics 59:5, pages 583-592.
Crossref
Crossref
T. Tateishi, Y. Krivoruk, Y-F. Ueng, A. J. J. Wood, F. P. Guengerich & M. Wood. (1996) Identification of Human Liver Cytochrome P-450 3A4 as the Enzyme Responsible for Fentanyl and Sufentanil N-Dealkylation. Anesthesia & Analgesia 82:1, pages 167-172.
Crossref
Crossref
T. Tateishi, Y. Krivoruk, Y-F. Ueng, A. J. J. Wood, F. P. Guengerich & M. Wood. (1996) Identification of Human Liver Cytochrome P-450 3A4 as the Enzyme Responsible for Fentanyl and Sufentanil N-Dealkylation. Anesthesia & Analgesia 82:1, pages 167-172.
Crossref
Crossref
A. David Rodrigues. 1996. Cytochrome P450, Part B. Cytochrome P450, Part B
186
195
.
Alexis Polles & James L. Griffith. (1996) Dextromethorphan-Induced Mania. Psychosomatics 37:1, pages 71-74.
Crossref
Crossref
William D. Figg, George E. Dukes, Henry R. Lesesne, Stanley W. Carson, Stephen S. Songer, J. Fred Pritchard, David J. Hermann, J. Robert Powell & Lawrence J. Hak. (2012) Comparison of Quantitative Methods to Assess Hepatic Function: Pugh's Classification, Indocyanine Green, Antipyrine, and Dextromethorphan. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 15:6, pages 693-700.
Crossref
Crossref
Anne T Harvey & Michael Burke. (1995) Comment on: The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease. The American Journal of Emergency Medicine 13:5, pages 605-606.
Crossref
Crossref
NL Kerry, AA Somogyi, F Bochner & G Mikus. (2012) The role of CYP2D6 in primary and secondary oxidative metabolism of dextromethorphan: in vitro studies using human liver microsomes.. British Journal of Clinical Pharmacology 38:3, pages 243-248.
Crossref
Crossref
J.Christopher Gorski, David R. Jones, Steven A. Wrighton & Stephen D. Hall. (1994) Characterization of dextromethorphan N-demethylation by human liver microsomes. Biochemical Pharmacology 48:1, pages 173-182.
Crossref
Crossref
J. Caslavska, E. Hufschmid, R. Theurillat, C. Desiderio, H. Wolfisberg & W. Thormann. (1994) Screening for hydroxylation and acetylation polymorphisms in man via simultaneous analysis of urinary metabolites of mephenytoin, dextromethorphan and caffeine by capillary electrophoretic procedures. Journal of Chromatography B: Biomedical Sciences and Applications 656:1, pages 219-231.
Crossref
Crossref
E. Spina, G.M. Campo, A. Avenoso, A.P. Caputi, P. Zuccaro, R. Pacifici, G. Gatti, G. Strada, A. Bartoli & E. Perucca. (1994) CYP2D6-related oxidation polymorphism in Italy. Pharmacological Research 29:3, pages 281-289.
Crossref
Crossref
MARIE-ANNE LAURENT-KENESI, CHRISTIAN FUNCK-BRENTANO, JEAN-MARIE POIRIER, DOMINIQUE DECOLIN & PATRICE JAILLON. (1993) Influence of CYP2D6-dependent metabolism on the steady-state pharmacokinetics and pharmacodynamics of metoprolol and nicardipine, alone and in combination. British Journal of Clinical Pharmacology 36:6, pages 531-538.
Crossref
Crossref
Y. M. Irshaid, H. F. Al-Hadidi & N. M. Rawashdeh. (1993) Dextromethorphan O-demethylation polymorphism in Jordanians. European Journal of Clinical Pharmacology 45:3, pages 271-273.
Crossref
Crossref
Y. M. Irshaid, H. F. Al-Hadidi & N. M. Rawashdeh. (1993) Lack of association between glucose-6-phosphate dehydrogenase deficiency and dextromethorphan O-demethylation polymorphism. European Journal of Clinical Pharmacology 44:3, pages 303-304.
Crossref
Crossref
Nicole L. Kerry, Andrew A. Somogyi, Gerd Mikus & Felix Bochner. (1993) Primary and secondary oxidative metabolism of dextromethorphan. Biochemical Pharmacology 45:4, pages 833-839.
Crossref
Crossref
S. Li, K. Fried, I. W. Wainer & D. K. Lloyd. (1993) Determination of dextromethorphan and dextrorphan in urine by capillary zone electrophoresis: Application to the determination of debrisoquin-oxidation metabolic phenotype. Chromatographia 35:3-4, pages 216-222.
Crossref
Crossref
F Broly, N Vandamme, C Libersa & M Lhermitte. (1991) The metabolism of mexiletine in relation to the debrisoquine/sparteine- type polymorphism of drug oxidation.. British Journal of Clinical Pharmacology 32:4, pages 459-466.
Crossref
Crossref
F. Nsabiyumva, Y. Furet, E. Autret, A. P. Jonville & M. Breteau. (1991) Oxidative polymorphism of dextromethorphan in a Burundi population. European Journal of Clinical Pharmacology 41:1, pages 75-77.
Crossref
Crossref
M. E. Veronese & S. McLean. (1991) Debrisoquine oxidation polymorphism in a Tasmanian population. European Journal of Clinical Pharmacology 40:5, pages 529-532.
Crossref
Crossref
Michael Spino. (1991) Pharmacokinetics of drugs in cystic fibrosis. Clinical Reviews in Allergy 9:1-2.
Crossref
Crossref
E. J. Calabrese. 1991. Ecogenetics. Ecogenetics
21
55
.
P L ColeA D BeamerN McGowanC O CantillonK BenfellR A KellyL H HartleyT W SmithE M Antman. (1990) Efficacy and safety of perhexiline maleate in refractory angina. A double-blind placebo-controlled clinical trial of a novel antianginal agent.. Circulation 81:4, pages 1260-1270.
Crossref
Crossref
F. Broly, C. Libersa, M. Lhermitte & B. Dupuis. (1990) Inhibitory studies of mexiletine and dextromethorphan oxidation in human liver microsomes. Biochemical Pharmacology 39:6, pages 1045-1053.
Crossref
Crossref
M. Pirovino, U. Honegger, O. Müller, Th. Zysset, A. Küpfer, M. Tinel & D. Pessayre. (1990) Differences in hepatic drug accumulation and enzyme induction after chronic amiodarone feeding of two rat strains: role of the hydroxylator phenotype?. British Journal of Pharmacology 99:1, pages 35-40.
Crossref
Crossref
P. Baumann. 1990. Therapieresistenz unter Antidepressiva-Behandlung. Therapieresistenz unter Antidepressiva-Behandlung
85
98
.
Michael Spino. 1990. Cystic Fibrosis. Cystic Fibrosis
169
210
.
G K SteinbergJ SalehD KunisR DeLaPazS R Zarnegar. (1989) Protective effect of N-methyl-D-aspartate antagonists after focal cerebral ischemia in rabbits.. Stroke 20:9, pages 1247-1252.
Crossref
Crossref
Gary K. Steinberg, Jamshid Saleh, Robert DeLaPaz, David Kunis & S. Rami Zarnegar. (1989) Pretreatment with the NMDA antagonist dextrorphan reduces cerebral injury following transient focal ischemia in rabbits. Brain Research 497:2, pages 382-386.
Crossref
Crossref
F Broly, C Libersa, M Lhermitte, P Bechtel & B Dupuis. (2012) Effect of quinidine on the dextromethorphan O‐demethylase activity of microsomal fractions from human liver.. British Journal of Clinical Pharmacology 28:1, pages 29-36.
Crossref
Crossref
M. Hildebrand, W. Seifert & A. Reichenberger. (1989) Determination of dextromethorphan metabolizer phenotype in healthy volunteers. European Journal of Clinical Pharmacology 36:3, pages 315-318.
Crossref
Crossref
W. Kalow. 1989. Clinical Pharmacology in Psychiatry. Clinical Pharmacology in Psychiatry
148
162
.
G K SteinbergC P GeorgeR DeLaPazD K ShibataT Gross. (1988) Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits.. Stroke 19:9, pages 1112-1118.
Crossref
Crossref
Thomas Zysset, Tanja Zeugin & Adrian Küpfer. (1988) In-vivo and in-vitro dextromethorphan metabolism in SD and DA rat. Biochemical Pharmacology 37:16, pages 3155-3160.
Crossref
Crossref
Charles P. George, Mark P. Goldberg, Dennis W. Choi & Gary K. Steinberg. (1988) Dextromethorphan reduces neocortical ischemic neuronal damage in vivo. Brain Research 440:2, pages 375-379.
Crossref
Crossref
N. Motassim, D. Decolin, T. Le Dinh, A. Nicolas & G. Siest. (1987) Direct determination of dextromethorphan and its three metabolites in urine by high-performance liquid chromatography using a precolumn switching system for sample clean-up. Journal of Chromatography B: Biomedical Sciences and Applications 422, pages 340-345.
Crossref
Crossref
W. Kalow. (1987) Genetic variation in the human hepatic cytochrome P-450 system. European Journal of Clinical Pharmacology 31:6, pages 633-641.
Crossref
Crossref
W. Kalow. 1987. Human Genetics. Human Genetics
507
516
.